Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals
Per visualizzare il file, fai click su questo link: Therapeutic monoclonal antibodies scFv patents as a marker of a new class of potential biopharmaceuticals.pdf